NSEGeneral Updates29 Jun 2026 · 29 Jun 2026, 07:56 pm
General Updates
Healthcare Global Enterprises Limited · HCG
✦ AI SummaryDivestiture
Healthcare Global Enterprises Limited has completed the transfer of 99.999% of its equity shareholding in BACC Health Care Private Limited to Inviga Healthcare Fund I and its nominee, with the initial consideration of INR 28.23 crores received on June 29, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Healthcare Global Enterprises Limited has informed the Exchange that further to the intimation dated May 19, 2026, with respect to the approval of the Board of Directors of Company granted on May 19, 2026, for the execution of the Share Purchase Agreement (SPA) dated 19 May 2026 with BACC Health Care Private Limited (BACC) and Inviga Healthcare Fund I and its nominee (Buyer) in relation to the sale of the Company's entire equity shareholding in BACC to the Buyer, in accordance with the provisions of the SPA, the Company would like to inform you that out of the total number of 93,578 shares of BACC held by the Company, the transfer of 93,577 shares which constitutes approximately 99.999% shares of BACC as contemplated under the SPA has been completed on June 29, 2026 in accordance with the terms thereof. Please note that the transfer of 1 share of BACC held by a nominee on behalf of the Company is under process.
Attachments (1)
📄pdf
Download →
HCG1_29062026195559_HCG_Intimation_-_BACC_Closing_-_29Jun2026.pdf
View document text
June 29, 2026
National Stock Exchange of India Limited, BSE Limited,
Compliance Department, Compliance Department,
Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers,
Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001,
Maharashtra, India Maharashtra, India
Dear Sir/Madam,
Subject: Intimation regarding completion of divestment by HealthCare Global Enterprises
Limited (“the Company”) of its entire equity shareholding in BACC Health Care
Private Limited pursuant to the Share Purchase Agreement dated May 19, 2026
Stock Code: BSE – 539787, NSE – HCG
Reference: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“LODR Regulations”), read with SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 issued on July 11, 2023, and last
updated on January 30, 2026 (“SEBI Circular”)
Further to our intimation dated May 19, 2026, with respect to the approval of the Board of Directors of
Company granted on May 19, 2026, for the execution of the Share Purchase Agreement (“SPA”) dated
May 19, 2026 with BACC Health Care Private Limited (“BACC”) and Inviga Healthcare Fund I and
its nominee (“Buyer”) in relation to the sale of the Company's entire equity shareholding in BACC to
the Buyer, in accordance with the provisions of the SPA, we would like to inform you that out of the
total number of 93,578 shares of BACC held by the Company, the transfer of 93,577 shares which
constitutes approximately 99.999% shares of BACC as contemplated under the SPA has been completed
on June 29, 2026 in accordance with the terms thereof. Please note that the transfer of 1 share of BACC
held by a nominee on behalf of the Company is under process.
As mentioned in the intimation dated May 19, 2026, out of the total consideration of INR 37,64,44,788
(Indian Rupees Thirty-Seven Crores Sixty-Four Lakhs Forty-Four Thousand Seven Hundred and
Eighty-Eight Only) payable by the Buyer to the Company under the SPA for the transfer of the entire
shareholding of the Company in BACC, the initial consideration is INR 28,23,33,591 (Indian Rupees
Twenty-Eight Crores Twenty Three Lakhs Thirty-Three Thousand Five Hundred and Ninety-One Only)
and the balance deferred consideration is payable within 18 (eighteen) months of the date of signing of
the SPA (i.e., May 19, 2026). The initial consideration referenced hereinabove has been received today
i.e. June 29, 2026. The deferred consideration referenced hereinabove is only time-deferred, and is not
a conditional or contingent payment.
Detailed disclosures with respect to the signing of the SPA, and sale of the Company’s entire equity
shareholding in BACC to the Buyer have already been intimated to the stock exchanges vide our letter
HealthCare Global Enterprises Limited
Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India
Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India
91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489
Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag
dated May 19, 2026; and there are no additional disclosures required to be made in this regard in terms
of the SEBI Circular.
Kindly take this on record and acknowledge receipt of this intimation.
Thanking you,
For HealthCare Global Enterprises Limited
Sunu Manuel
Company Secretary & Compliance Officer
HealthCare Global Enterprises Limited
Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India
Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India
91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489
Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag